Currently Viewing
Finally, good news for triple negative breast cancer patients!
June 09, 2009 – Susan McClure
Got cancer? Blame it on Drew's cancer
June 09, 2009 – Elizabeth Whittington
Cancer Treatment Gets Personal
June 08, 2009 – Elizabeth Whittington
Fundraiser this weekend to help a sick dog
June 08, 2009 – Melissa Weber
PARP inhibitors create buzz at ASCO
June 08, 2009 – Debu Tripathy
Update from ASCO: Personalizing breast cancer treatment
June 08, 2009 – Debu Tripathy
Young, in love, and diagnosed
June 08, 2009 – Kathy LaTour
Testing for HER2 Overexpression in Breast Cancer
June 08, 2009 – Karen Patterson
Avastin Falls Short in Early-Stage Colon Cancer
June 06, 2009 – Melissa Weber

Finally, good news for triple negative breast cancer patients!

BY Susan McClure
PUBLISHED June 09, 2009
During ASCO's annual meeting this year, I was thrilled to learn that a new drug class is offering promise to patients with triple negative breast cancer. PARP inhibitors--experimental targeted therapy medicines, may make chemotherapy work better against aggressive forms of breast cancer (see Debu Tripathy's blog for the details). For years, I've been happy to see great advancements in the treatment of breast cancer, but have selfishly been concerned that no real progress was being made to better understand triple-negative cancers. When I was diagnosed with breast cancer back in 1994, the term "triple-negative" breast cancer didn't exist. Diagnostic tests weren't as sophisticated as they are today. I did know that I was estrogen receptor-negative and that while my cancer was aggressive, it hadn't spread to my lymph nodes. I had surgery, chemotherapy, and radiation. Within six months my treatment was over, and I was told to get on with my life. Six months of treatment and I was done. So why were some of my friends, also estrogen receptor-negative, not so fortunate? It was years later, during a routine check up with my oncologist that I asked him to review my pathology report to see if he thought that I might have fallen into the triple-negative camp. After close examination, he shrugged his shoulders and said that, most likely, I did. To be sure, they'd have to go down to the basement of Baylor, find my 12-year-old tumor, and run it through the gauntlet of diagnostic tests now available to determine such things. Eeek. I've been cancer free for twelve years. I've lived with never really knowing what caused my cancer. I've lived with the fear that it might return--as we all do. I've lost friends with triple-negative breast cancer who ran out of treatment options far before they ran out of hope. For me, this new development honors their memory.
Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In